All Stories

  1. The Risk of Reinfection or Primary Hepatitis E Virus Infection at a Liver Transplant Center in Brazil: An Observational Cohort Study
  2. Investigation of etiology of community-acquired pneumonia in hospitalized patients in a tertiary hospital of São Paulo City, Brazil
  3. Phylodynamic of SARS-CoV-2 during the second wave of COVID-19 in Peru
  4. High Frequency of Antiviral Resistance Mutations in HBV Genotypes A2 and H: Multidrug Resistance Strains in Mexico
  5. Detection of Hepatitis E Virus Genotype 3 in Feces of Capybaras (Hydrochoeris hydrochaeris) in Brazil
  6. PNPLA3 GENE POLYMORPHISM AND RED MEAT CONSUMPTION INCREASED FIBROSIS RISK IN NASH BIOPSY-PROVEN PATIENTS UNDER MEDICAL FOLLOW-UP IN A TERTIARY CENTER IN SOUTHWEST BRAZIL
  7. Associations of SARS-CoV-2 cycle threshold values with age, gender, sample collection setting, and pandemic period
  8. High prevalence of hepatitis B virus and low vaccine response in children and adolescents in Northeastern Brazil
  9. Antimicrobial oral lavage reduces the SARS-CoV-2 load in intubated patients: randomized clinical trial
  10. Effectiveness of Toothpastes on SARS-CoV-2 Viral Load in Saliva
  11. Hepatitis B Virus Infection among Japanese Immigrants and Descendants: The Need to Strengthen Preventive and Control Measures
  12. Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence
  13. Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers
  14. Seroprevalence of hepatitis B, C and D markers in indigenous patients seen at the Native American Outpatient Clinic of Universidade Federal de São Paulo
  15. Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis
  16. The Molecular Characterization of Hepatitis A Virus Strains Circulating during Hepatitis A Outbreaks in São Paulo, Brazil, from September 2017 to May 2019
  17. Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients
  18. Self-collected unstimulated saliva, oral swab, and nasopharyngeal swab specimens in the detection of SARS-CoV-2
  19. Detection and Genetic Characterization of Hepatitis B and D Viruses: A Multi-Site Cross-Sectional Study of People Who Use Illicit Drugs in the Amazon Region
  20. Long term persistence of coronavirus SARS-CoV-2 infection
  21. Detection of coronavirus-2 by real-time reverse transcription polymerase chain reaction in conjunctival swabs from patients with severe form of Coronavirus disease 2019 in São Paulo, Brazil
  22. Hepatitis B in the Northwestern region of Sao Paulo State: genotypes and resistance mutations
  23. Hepatitis B Virus Infection among People Who Use Illicit Drugs: Prevalence, Genotypes and Risk Factors in the State of Amapá, Northern Brazil
  24. Hepatitis C Virus among Female Sex Workers: A Cross-Sectional Study Conducted along Rivers and Highways in the Amazon Region
  25. Efficacy of sofosbuvir as treatment for yellow fever: protocol for a randomised controlled trial in Brazil (SOFFA study)
  26. Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy
  27. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure
  28. Key features associated with HBV exposure in female sex workers.
  29. Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region
  30. HBV infection among female sex workers in the coastal area of the Brazilian Amazon
  31. Lipase and factor V (but not viral load) are prognostic factors for the evolution of severe yellow fever cases
  32. Guillain–Barré syndrome—the challenge of unrecognized triggers
  33. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population
  34. Epidemiology of viral respiratory infections in children undergoing heart surgery
  35. Liver Transplantation for Fulminant Hepatitis Attributed to Yellow Fever
  36. Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]
  37. Evaluation of Influenza A H1N1 infection and antiviral utilization in a tertiary care hospital
  38. An Outbreak of Human Parvovirus B19 Hidden by Dengue Fever
  39. Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
  40. Prevalence of naturally occurring amino acid substitutions associated with resistance to hepatitis C virus NS3/NS4A protease inhibitors in São Paulo state
  41. A novel hepatitis B virus species discovered in capuchin monkeys sheds new light on the evolution of primate hepadnaviruses
  42. Molecular diagnosis of Strongyloides stercoralis among transplant candidates
  43. Prevalence of hepatitis delta virus among hemodialysis and renal transplant patients
  44. Clinical Applications of Point-of-Care Testing in Different Conditions
  45. Hallmarks of liver lesions in pigs naturally infected by hepatitis E virus genotype 3
  46. High Prevalence of Hepatitis B Subgenotype D4 in Northeast Brazil: an Ancient Relic from African Continent?
  47. Point-of-Care Testing: General Aspects
  48. Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon
  49. Prevalence of naturally occurring NS5A resistance-associated substitutions in patients infected with hepatitis C virus subtype 1a, 1b, and 3a, co-infected or not with HIV in Brazil
  50. Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil
  51. Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseases
  52. Characterization of clinical predictors of naturally occurring NS3/NS4A protease polymorphism in genotype 1 hepatitis C virus mono and HIV co-infected patients
  53. Distribution of HBV subgenotypes in Ribeirão Preto, Southeastern Brazil: a region with history of intense Italian immigration
  54. Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection
  55. Persistence of Zika Virus in Breast Milk after Infection in Late Stage of Pregnancy
  56. Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism
  57. Precision Medicine
  58. Cascade of care and predictors of loss to follow-up among patients with hepatitis C.
  59. Mutation in the S geneadeterminant of the hepatitis B virus associated with concomitant HBsAg and anti-HBs in a population in Northeastern Brazil
  60. Characterization of hepatitis B virus infection in illicit drug users in the Marajó Archipelago, northern Brazil
  61. Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV
  62. High prevalence of HBV/A1 subgenotype in native south Americans may be explained by recent economic developments in the Amazon
  63. The hepatitis delta genotype 8 in Northeast Brazil: The North Atlantic slave trade as the potential route for infection
  64. Interferon lambda and hepatitis C virus core protein polymorphisms associated with liver cancer
  65. HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing
  66. Association of IFNL3 and IFNL4 polymorphisms with hepatitis C virus infection in a population from southeastern Brazil
  67. Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico
  68. A Novel Assay for the Identification of NOTCH1 PEST Domain Mutations in Chronic Lymphocytic Leukemia
  69. Association of Lactase Persistence Genotypes with High Intake of Dairy Saturated Fat and High Prevalence of Lactase Non-Persistence among the Mexican Population
  70. DIAGNOSIS OF Strongyloides stercoralis INFECTION IN IMMUNOCOMPROMISED PATIENTS BY SEROLOGICAL AND MOLECULAR METHODS
  71. Resistance-associated variants in HCV subtypes 1a and 1b detected by Ion Torrent sequencing platform
  72. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry
  73. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3
  74. Diagnosis of the strongyloid nematode Strongyloides venezuelensis in experimentally infected rats
  75. Characteristics of an outpatient chronic hepatitis B virus infection cohort
  76. Molecular diagnosis of strongyloidiasis in tropical areas: a comparison of conventional and real-time polymerase chain reaction with parasitological methods
  77. Comparative Study of the Accuracy of Different Techniques for the Laboratory Diagnosis of Schistosomiasis Mansoni in Areas of Low Endemicity in Barra Mansa City, Rio de Janeiro State, Brazil
  78. HBV carrying drug-resistance mutations in chronically infected treatment-naive patients
  79. HepacivirusInfection in Domestic Horses, Brazil, 2011–2013
  80. Evaluation of real-time PCR assay to detect Schistosoma mansoni infections in a low endemic setting
  81. IL28B Gene Polymorphism SNP rs8099917 Genotype GG Is Associated with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in HTLV-1 Carriers
  82. Detection of Schistosoma mansoni infection by TaqMan® Real-Time PCR in a hamster model
  83. Detection of Schistosoma mansoni Antibodies in a Low-Endemicity Area Using Indirect Immunofluorescence and Circumoval Precipitin Test
  84. High prevalence of hepatitis B virus subgenotypes A1 and D4 in Maranhão state, Northeast Brazil
  85. SeptiFast for diagnosis of sepsis in severely ill patients from a Brazilian hospital
  86. Conventional PCR for molecular diagnosis of human strongyloidiasis
  87. Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype 1 patients with or without HIV coinfection
  88. Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B
  89. Distribution of hepatitis B virus subgenotype F2a in São Paulo, Brazil
  90. Improving the diagnosis of meningitis due to enterovirus and herpes simplex virus I and II in a tertiary care hospital
  91. The use of exogenous iron by professional cyclists pervades abdominal organs but not the heart
  92. HCV viremia drives an increment of CD86 expression by myeloid dendritic cells
  93. Absence of anti-hepatitis B virus (HBV) core in HIV/HBV coinfection with advanced immunosuppression
  94. On Hepatitis C Virus Evolution: The Interaction between Virus and Host towards Treatment Outcome
  95. Phylogenetic analysis and subgenotypic distribution of the hepatitis B virus in Recife, Brazil
  96. Analysis of HCV quasispecies dynamic under selective pressure of combined therapy
  97. One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus
  98. Genetic diversity of HCV in Brazil
  99. An update on HDV: virology, pathogenesis and treatment
  100. Anatomo-clinical and molecular description of liver neotropical echinococcosis caused by Echinococcus oligarthrus in human host
  101. Distribution of HBV genotypes in Latin America
  102. Epidemiological update of hepatitis B, C and delta in Latin America
  103. Epidemiology, virology and pathogenesis of viral hepatitis with a focus on Latin America
  104. Evolutionary rates and HBV: issues of rate estimation with Bayesian molecular methods
  105. Origin of HBV and its arrival in the Americas – the importance of natural selection on time estimates
  106. Phylogenetic analysis of complete genome sequences of hepatitis B virus from an Afro-Colombian community: presence of HBV F3/A1 recombinant strain
  107. Distribution and molecular characterization of hepatitis C virus (HCV) genotypes in patients with chronic infection from Pernambuco State, Brazil
  108. Corrigendum to ‘‘Hepatitis B virus genotypes from European origin explains the high endemicity found in some areas from southern Brazil” [Infect. Genet. Evol. 12 (2012) 1295–1304]
  109. Two sequential PCR amplifications for detection of Schistosoma mansoni in stool samples with low parasite load
  110. Detecção de mutações no gene KIT em leucemia mieloide aguda
  111. HEV infection in swine from Eastern Brazilian Amazon: Evidence of co-infection by different subtypes
  112. Hepatitis B virus genotypes from European origin explains the high endemicity found in some areas from southern Brazil
  113. Analysis of Hepatitis C Virus Intrahost Diversity across the Coding Region by Ultradeep Pyrosequencing
  114. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?
  115. IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
  116. Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil
  117. Hepatitis Delta virus genotype 8 infection in Northeast Brazil: Inheritance from African slaves?
  118. Detection of Hepatitis B virus subgenotype A1 in a Quilombo community from Maranhão, Brazil
  119. Dynamics of Hepatitis D (delta) virus genotype 3 in the Amazon region of South America
  120. Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with Hepatitis B (HBV) or Hepatitis C (HCV) infection
  121. Phylogenetic analysis of hepatitis B virus genotype F complete genome sequences from Chilean patients with chronic infection
  122. Hepatitis B (HBV), Hepatitis C (HCV) and Hepatitis Delta (HDV) Viruses in the Colombian Population—How Is the Epidemiological Situation?
  123. Distribution of hepatitis c virus (hcv) genotypes in patients with chronic infection from Rondônia, Brazil
  124. Molecular characterization of the Hepatitis B virus genotypes in Colombia: A Bayesian inference on the genotype F
  125. Molecular characterization, distribution, and dynamics of hepatitis C virus genotypes in blood donors in Colombia
  126. High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B
  127. Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients
  128. Social Networks Shape the Transmission Dynamics of Hepatitis C Virus
  129. A real-time quantitative assay for hepatitis B DNA virus (HBV) developed to detect all HBV genotypes
  130. Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response
  131. Seroprevalence of human toxocariasis in Andean communities from the Northeast of Lima, Peru
  132. Characterization of a Hepatitis B virus strain in southwestern Paraná, Brazil, presenting mutations previously associated with anti-HBs Resistance
  133. HBV markers in haemodialysis Brazilian patients: a prospective 12-month follow-up
  134. Sequencing of E2 and NS5A regions of HCV genotype 3a in Brazilian patients with chronic hepatitis
  135. Characterization of Hepatitis B virus (HBV) genotypes in patients from Rondônia, Brazil
  136. Molecular evidence of horizontal transmission of hepatitis C virus within couples
  137. Molecular epidemiology and genetic diversity of hepatitis B virus genotype E in an isolated Afro-Colombian community
  138. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation
  139. Simultaneous quantitation of serum HBV DNA and HBeAg can distinguish between slow and fast viral responses to antiviral therapy in patients with chronic hepatitis B
  140. Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (Labrea black fever) in the western Brazilian Amazon region
  141. Quasispecies of hepatitis C virus genotype 1 and treatment outcome with Peginterferon and Ribavirin☆
  142. A phylogenetic study of hepatitis B virus in chronically infected Brazilian patients of Western and Asian descent
  143. Positive Selection Results in Frequent Reversible Amino Acid Replacements in the G Protein Gene of Human Respiratory Syncytial Virus
  144. Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin
  145. Boosting Virology in Brazil
  146. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil
  147. Hepatitis B virus genotype E detected in Brazil in an African patient who is a frequent traveler
  148. Soroprevalência da hepatite B e avaliação da resposta imunológica à vacinação contra a hepatite B por via intramuscular e intradérmica em profissionais de um laboratório de saúde pública
  149. Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil
  150. Correction: Braz J Med Biol Res 2006; 39 (12): 1575-1580: HFE gene mutations in Brazilian thalassemic patients
  151. HFE gene mutations in Brazilian thalassemic patients
  152. HFE gene mutations in Brazilian thalassemic patients
  153. Distribution of hepatitis B virus genotypes among patients with chronic infection
  154. Correction
  155. P.270 Analysis of interferon based therapy response in patients infected with hepatitis C genotype 1 and 3 virus
  156. P.492 Epidemiological study of the hepatitis C virus transmission routes associated to genotyping
  157. P.299 Genotype 5 hepatitis C virus: a rare case in Brazil
  158. P.002 Low occurrence of occult hepatitis B virus infection (HBV) in patients with liver cirrhosis due to hepatitis C virus (HCV) with or without hepatocellular carcinoma (HCC)
  159. A prospective study of hepatitis B virus markers in patients with chronic HBV infection from Brazilian families of Western and Asian origin
  160. The precore mutation is associated with severity of liver damage in Brazilian patients with chronic hepatitis B
  161. Hepatitis B Virus Genotypes and Precore and Core Mutants in Brazilian Patients
  162. Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology
  163. A prospective study of the prevalence of hepatitis B and C virus co-infection among patients with chronic renal disease under hemodialysis
  164. The reporting of theoretical health risks by the media: Canadian newspaper reporting of potential blood transmission of Creutzfeldt-Jakob disease
  165. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies
  166. High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study
  167. Early clearance kinetics of hepatitis C virus (HCV) in patients with chronic hepatitis C under therapy with pegylated-interferon (PEG-IFN) alpha-2b or consensus-interferon (CIFN) plus ribavirin
  168. Early viral kinetics of hepatitis C virus (HCV) genotype 3 with very frequent sampling analysis
  169. Longitudinal analysis of changes in early HCV kinetics following the addition of ribavirin to IFN monotherapy
  170. Study of hepatitis B virus (HBV) genotypes in families of patients with chronic HBV infection: comparison of asian and ocidental origin people in Brazil
  171. Efficacy and tolerability of long-term therapy using high lamivudine doses for the treatment of chronic hepatitis B
  172. Hepatitis E Virus Immunoglobulin G Antibodies in Different Populations in Campinas, Brazil
  173. Quantitation of HIV-1 RNA Viral Load Using NASBA Methodology and Comparison with other Surrogate Markers for Disease Progression
  174. Elevated alanine aminotransferase in Brazilian blood donors
  175. Expression of the hepatitis B virus surface antigen in mammalian cells using an Epstein-Barr-virus-derived vector
  176. Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection
  177. Transient expression of hepatitis B virus surface antigen (HBsAg) gene in monkey cells by a SV40-based virus vector
  178. Human T Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis in Sao Paulo, Brazil
  179. Expression of the 18kDa protein of Mycobacterium leprae in Saccharomyces cerevisiae